Express Scripts

RELEASE: Innovative value-based SafeGuardRx® program delivers better care at lower cost for Express Scripts’ patients and plan sponsors

ST. LOUIS /PRNewswire/ — Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx® programs. Using available evidence […]

RELEASE: Express Scripts Announces 2018 First Quarter Results

ST. LOUIS, May 2, 2018 /PRNewswire/ — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted share was $1.77.* The Company reaffirms its core business¹ 2018 adjusted […]